G1 THERAPEUTICS INC(NASDAQ:GTHX) stock News

GTHX Latest News, Press Relases and Analysis

All

Press Releases

11 months ago - By: G1 Therapeutics

Pharmacosmos Group and G1 Therapeutics Announce Successful Closing of Tender Offer

11 months ago - By: G1 Therapeutics

Pharmacosmos Group and G1 Therapeutics Announce Successful Closing of Tender Offer

a year ago - By: InvestorPlace

Why Is G1 Therapeutics (GTHX) Stock Up 66% Today?

a year ago - By: G1 Therapeutics; Pharmacosmos

Pharmacosmos Group to Acquire G1 Therapeutics

a year ago - By: InvestorPlace

Biotech Bombshell: G1 Therapeutics Stock Is Too Much of a Gamble

a year ago - By: G1 Therapeutics

G1 Therapeutics Added to the Russell 2000® and 3000® Indexes

a year ago - By: G1 Therapeutics

Pharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period

a year ago - By: G1 Therapeutics

Pharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period

a year ago - By: Halper Sadeh LLC - Mentions: GVP PETQ

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GVP, PETQ, GTHX on Behalf of Shareholders

a year ago - By: Brodsky & Smith LLC - Mentions: TWKS PETQ GVP

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Thoughtworks Holding, Inc. (Nasdaq – TWKS), PetIQ, Inc. (Nasdaq – PETQ), G1 Therapeutics, Inc. (Nasdaq – GTHX), GSE Solutions, Inc. (Nasdaq – GVP)

a year ago - By: Kahn Swick & Foti, LLC

G1 THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of G1 Therapeutics, Inc. - GTHX

a year ago - By: Halper Sadeh LLC - Mentions: PETQ

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GTHX, PETQ on Behalf of Shareholders

a year ago - By: Brodsky & Smith LLC - Mentions: TWKS PETQ GVP

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Thoughtworks Holding, Inc. (Nasdaq – TWKS), PetIQ, Inc. (Nasdaq – PETQ), G1 Therapeutics, Inc. (Nasdaq – GTHX), GSE Solutions, Inc. (Nasdaq – GVP)

a year ago - By: G1 Therapeutics

G1 Therapeutics Provides Second Quarter 2024 Financial Results and Operational Highlights

a year ago - By: G1 Therapeutics

G1 Therapeutics Provides Second Quarter 2024 Financial Results and Operational Highlights

a year ago - By: Benzinga - Mentions: STEM CVS UPST PETQ ...

Dow Tumbles Over 200 Points; CVS Health Cuts Profit Forecast

a year ago - By: Benzinga - Mentions: STEM UPST PETQ TLIS ...

Crude Oil Jumps Over 3%; Upstart Shares Spike Higher

a year ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether G1 Therapeutics, Inc. has obtained a Fair Price for its Public Shareholders

a year ago - By: Halper Sadeh LLC

GTHX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of G1 Therapeutics, Inc. Is Fair to Shareholders

a year ago - By: InvestorPlace - Mentions: CYRX DZSI EBS EVAV ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

a year ago - By: G1 Therapeutics; Pharmacosmos

Pharmacosmos Group to Acquire G1 Therapeutics

a year ago - By: G1 Therapeutics

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

a year ago - By: G1 Therapeutics

G1 Therapeutics to Release Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024

a year ago - By: G1 Therapeutics

G1 Therapeutics to Release Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024

a year ago - By: BusinessInsider

G1 Therapeutics Stock: The Undervalued Gem Poised for a 30% Revenue Surge by 2025

a year ago - By: InvestorPlace

G1 Therapeutics Stock: The Undervalued Gem Poised for a 30% Revenue Surge by 2025

a year ago - By: InvestorPlace - Mentions: ALNY DNA

Coffee Recall 2024: Over 250 Coffee Products Recalled Due to Botulism Fears

a year ago - By: InvestorPlace - Mentions: DNA DMTK EPOW

Ginkgo Bioworks Layoffs 2024: What to Know About the Latest DNA Job Cuts

a year ago - By: InvestorPlace - Mentions: DMTK EPOW AGFY

Why Is G1 Therapeutics (GTHX) Stock Down 56% Today?

a year ago - By: InvestorPlace - Mentions: AGFY EPOW GRI RDZN ...

G1 THERAPEUTICS INC (GTHX) Stock News

GTHX Latest News, Press Relases and Analysis

Pharmacosmos Group and G1 Therapeutics Announce Successful Closing of Tender Offer

Pharmacosmos Group and G1 Therapeutics Announce Successful Closing of Tender Offer

Why Is G1 Therapeutics (GTHX) Stock Up 66% Today?

Pharmacosmos Group to Acquire G1 Therapeutics

Biotech Bombshell: G1 Therapeutics Stock Is Too Much of a Gamble

G1 Therapeutics Added to the Russell 2000® and 3000® Indexes

Pharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period

Pharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GVP, PETQ, GTHX on Behalf of Shareholders

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Thoughtworks Holding, Inc. (Nasdaq – TWKS), PetIQ, Inc. (Nasdaq – PETQ), G1 Therapeutics, Inc. (Nasdaq – GTHX), GSE Solutions, Inc. (Nasdaq – GVP)

G1 THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of G1 Therapeutics, Inc. - GTHX

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GTHX, PETQ on Behalf of Shareholders

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Thoughtworks Holding, Inc. (Nasdaq – TWKS), PetIQ, Inc. (Nasdaq – PETQ), G1 Therapeutics, Inc. (Nasdaq – GTHX), GSE Solutions, Inc. (Nasdaq – GVP)

G1 Therapeutics Provides Second Quarter 2024 Financial Results and Operational Highlights

G1 Therapeutics Provides Second Quarter 2024 Financial Results and Operational Highlights

Dow Tumbles Over 200 Points; CVS Health Cuts Profit Forecast

Crude Oil Jumps Over 3%; Upstart Shares Spike Higher

Shareholder Alert: Ademi LLP investigates whether G1 Therapeutics, Inc. has obtained a Fair Price for its Public Shareholders

GTHX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of G1 Therapeutics, Inc. Is Fair to Shareholders

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Pharmacosmos Group to Acquire G1 Therapeutics

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

G1 Therapeutics to Release Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024

G1 Therapeutics to Release Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024

G1 Therapeutics Stock: The Undervalued Gem Poised for a 30% Revenue Surge by 2025

G1 Therapeutics Stock: The Undervalued Gem Poised for a 30% Revenue Surge by 2025

Coffee Recall 2024: Over 250 Coffee Products Recalled Due to Botulism Fears

Ginkgo Bioworks Layoffs 2024: What to Know About the Latest DNA Job Cuts

Why Is G1 Therapeutics (GTHX) Stock Down 56% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday